Production and Characterization of Transgenic Mice Harboring Mutant Human UMOD Gene

By Takiue Yuichi   Hosoyamada Makoto   Yokoo Takuya   Kimura Masaki   Ochiai Manami   Kaneko Kiyoko   Ichida Kimiyoshi   Hosoya Tatsuo   Shibasaki Toshiaki  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 27, Iss. 6-7, 2008-06 ,pp. : 596-600

Taylor & Francis Ltd

Access to resources Recommend Favorite

Inhibition of Clotting Factor XIII Activity by Nitric Oxide

By Catani M.V.   Bernassola F.   Rossi A.   Melino G.  

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 1, 1998-08 ,pp. : 275-278

Elsevier

Access to resources Recommend Favorite

Analysis of the N -glycans of recombinant human Factor IX purified from transgenic pig milk

By Gil Geun-Cheol   Velander William H   Van Cott Kevin E  

Glycobiology, Vol. 18, Iss. 7, 2008-07 ,pp. : 526-539

Oxford University Press

Access to resources Recommend Favorite

Methods for Preparation of Recombinant Cytokine Proteins V. Mutant Analogues of Human Interferon-γ with Higher Stability and Activity

By Pechenov S.E.   Tikhonov R.V.   Shingarova L.N.   Korobko V.G.   Yakimov S.A.   Klyushnichenko V.E.   Babajantz A.A.   Beliaev D.L.   Kuznetzov V.P.   Shvetz V.I.   Wulfson A.N.  

Protein Expression and Purification, Vol. 24, Iss. 2, 2002-03 ,pp. : 173-180

Academic Press

Access to resources Recommend Favorite

Bone Mass Loss Due to Estrogen Deficiency Is Compensated in Transgenic Mice Overexpressing Human Osteoblast Stimulating Factor-1

By Masuda H.   Tsujimura A.   Yoshioka M.   Arai Y.   Kuboki Y.   Mukai T.   Nakamura T.   Tsuji H.   Nakagawa M.   Hashimoto-Gotoh T.  

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 2, 1997-09 ,pp. : 528-533

Elsevier

Access to resources Recommend Favorite